Ge Shiqian War "Epidemic" Poetry Series
Release time:
2020-07-31

Author:
Ge Shiqian, a famous contemporary poet and writer. 1962 Born in Jiamusi City, Heilongjiang Province. Communist Party member, military background. He used to be the deputy editor-in-chief of "Chinese Literature" of the State Administration of Foreign Affairs, and the deputy director and deputy editor-in-chief of the "China Market Economy News" of the Party School of the Central Committee of the Communist Party of China. He is currently the chief writer of "People's Daily Minsheng Weekly"; the executive director of the Economics Research Institute of the National Business Alliance (Beijing); the director of the Legal Professional Committee of the China Enterprise Chamber of Commerce Alliance; and the vice chairman of the China Association for Poverty Alleviation.
has published more than 14,800 ,000 words of works at home and abroad, and dozens of them have been selected into Xinhua Digest and Selected Works of Famous Chinese Poets. Successfully planned and edited a large-scale collection of patriotic propaganda paintings "Cross-Century Exchange-Contemporary Chinese Scientists, Artists, and Entrepreneurs Talk Together 21th Century"; "Building a Corporate Image Project · Chinese Dragon Towards the New Century", etc. The long poem "China is a proud host" won the "Asian Games Outstanding Literary Works" Grand Prix jointly organized by the Propaganda Department of the Central Committee of the Communist Party of China, the Asian Games Organizing Committee, the People's Daily, CCTV and other management departments, literary organizations, and news units The highest award. The four-act drama "The Story of Young Deng Xiaoping" planned and written by him 1998 was performed in Shanxi Zhongnanhai in January, which was highly praised by party and state leaders and aroused strong repercussions in the society. In recent years, in addition to the normal editorial and literary creation, the "two front" literary theory has been put forward and constructed, and has become a practitioner of "two front" literature in China.
Three Towns Encountered Lei Daxue
-Gengzi Chuntan
Dedicated to War "Epidemic " Hero City Wuhan
Ge Shiqian
as Gengzi Suqing Day
Three Towns Encountered thunder snow
seal the city, it is by no means a lightning bolt of love
, which has cut off the clouds and changed
, tore up the gloomy
with a thunder, exploded
, and rolled
to raise the plain butterfly
clear snow like flocculent! Qingxue
Chuhe Han Street, Xiao Shu comforts
Yangtze River Bridge, light and nickname about
is " ding " heavy or Germany light
is Germany light or "ding" heavy
product only virtue only use
all hearts to the country, engraved Dagong
to delete many red tape
Sanchu pregnant with three towns
three towns holding three Chu
will be a complete Qin story
full of ink and light description, focus on
to push out the budding continuation
Guishan Pagoda's coordinates are very clear
the East Lake with great sorrow
What is the truth, what is the mystery of the next
? The answer to the riddle has been made clear to
. No need to call it a sad shirt
# Red Plum in 156 Disaster
# Red Plum in 159 Proud Snow
smiled, stretching spirit
a clump, a tree
which in decadence innocent wilt
when it is boxer suqing day
three towns meet thunder snow
first heart, can't throw
demon, the
are all pure long-cherished wishes
justice and bravery
will not be transformed into a tree on the peak of the valley
flower
or a feeling of thinking or looking at
, no longer numb
conscience will not be deceived by deception
greed, perfunctory and laziness
will no longer criticize
for no reason, ji Xue Di Xin
those drenched dirty souls
in urgent need of skin cutting
# migratory birds returning from 228
turn a corner
to enter the scenery
wings with sunshine
cold and trembling last night
no need to curse too much
wandering in the clear and clear, waste of intuition
victory has not been reported, song que in
poetry and Banlan
parrot to swallow
will no longer easily scare away
lost in trance direction
and return, standing as stele
boxer, the trend and the general trend
is not unpredictable. it is possible to simply predict
2020 -1
cups of tea and three towns of incense
" coronary "virus is taking advantage of
More information
Publicity of Environmental Protection Acceptance for Completion of Kiln End Flue Gas Desulfurization Project of daye peak cement co., ltd. According to the requirements of the Interim Measures for Environmental Protection Acceptance for Completion of Construction Projects (No.4 [2017] of the State Environmental Regulations) issued by the Ministry of Environmental Protection, the environmental protection acceptance information of "Kiln End Flue Gas Desulfurization Project" of daye peak cement co., ltd. is now publicized. Basic Information of 1. Project Project Name: Kiln End Flue Gas Desulfurization Project Construction Unit: daye Jianfeng Cement Co., Ltd. Project Construction Location: Yongguang Village, Baoan Town, daye city, nature of the project in the existing plant area of daye Jianfeng Cement Co., Ltd.: The construction content of the technological transformation project is: This technological transformation project is mainly to build a wet desulfurization system for kiln end gas of the company's existing 4000t cement clinker production line, adopting limestone-gypsum wet flue gas desulfurization process. The project covers a total area of 500 m2, with a new construction area of about 450 m2. It mainly builds desulfurization complex building, flue gas system, SO2 absorption system, limestone powder conveying and limestone slurry preparation system, process water system, gypsum dehydration system and supporting pipelines. Power supply, water supply, compressed air and other public works rely on the existing plant. Total investment and environmental protection investment: the total investment of the project is 10.37 million yuan, all of which are environmental protection investment. The project was entrusted to Huangshi Yangtze River Environmental Engineering Design and Research Institute to carry out environmental impact assessment in September 2017. On November 16, 2017, Daye Municipal Environmental Protection Bureau issued a reply with YEHAN [2017] No. 354. Implementation of 2. environmental protection measures The scope of this acceptance is the flue gas desulfurization system and supporting facilities at the end of the kiln. (1) Exhaust gas pollution
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31
Spike New Drug Approved for Registration
On April 16, Jianfeng Pharmaceutical Company received the approval and issuance of Olopatadine Hydrochloride Eye Drops "Drug Registration Approval" (approval number: 2019S00296) approved by the State Drug Administration. Olopatadine hydrochloride eye drops is mainly used to treat the signs and symptoms of allergic conjunctivitis. It is a mast cell stabilizer and a relatively selective histamine H1-receptor antagonist. It can inhibit type I immediate allergic reactions in vivo and in vitro experiments. At present, the product has been included in the "National Basic Medical Insurance, Work Injury Insurance and Maternity Insurance Drug Catalog (2017 Edition)" and classified as Class B. According to the relevant data of IMS database, in 2018, the global sales of olopatadine hydrochloride eye drops were about 0.37 billion US dollars, and the sales in China were about 10.232 million US dollars. Spike Pharmaceuticals already has the corresponding production line, this time to obtain the registration approval, marking Spike Pharmaceuticals has the qualification to carry out the production and sales of olopatadine hydrochloride eye drops, will further enrich the product line of Spike Pharmaceuticals, help to enhance the competitiveness of the company's pharmaceutical business. (Xia Yingpin)
2020
07-31